Aarnæs Maria Tyse, Sandvik Leiv, Brøndbo Kjell
Department of Otorhinolaryngology/Head and Neck Surgery, Oslo University Hospital, Rikshospitalet, Mailboks 4956, 0424, Oslo, Norway.
Department of Biostatistics, Oslo University Hospital, Oslo, Norway.
Eur Arch Otorhinolaryngol. 2017 May;274(5):2225-2228. doi: 10.1007/s00405-017-4512-0. Epub 2017 Feb 27.
A retrospective epidemiological study of patients treated for idiopathic subglottic stenosis (ISS) during 2003-2013 at Oslo University Hospital, Rikshospitalet, was undertaken to assess its incidence, management and treatment outcomes. Out of a total of 123 patients with subglottic stenosis (84 female, 39 men), 38 patients were diagnosed with ISS, all of whom were female. Of these, 23 lived in the South-Eastern Norway Regional Health Authority, representing an incidence of 0.2 per 100,000 (95% CI 0.13-0.3) in this region of 2.9 million inhabitants. Mean age at diagnosis was 54 years (range 20-85 years), and the mean interval between symptom onset and diagnosis was 3.1 years. The 38 patients with ISS underwent a total of 132 operations between 2003 and 2013. All patients were managed endoscopically using laser surgery, with or without corticosteroids and Mitomycin C, with dilatation by balloon or bougie. Eight patients (21.1%) required only one procedure, while 30 patients (78.9%) had multiple operations. The median follow-up for all patients from the first operation was 5.3 years. The mean interval between procedures was 1 year for patients aged 20-48 years, 1.3 years for patients aged 49-61 years and 3.0 years for patients aged 62-85 years. No clinically significant complications were observed. In conclusion, the symptoms of ISS can be treated effectively with laser surgery and dilatation but the recurrence rate remains high and the time interval between operations does not increase with time, making ISS a continuing challenge.
为评估特发性声门下狭窄(ISS)的发病率、管理和治疗结果,对2003年至2013年期间在奥斯陆大学医院里司医院接受治疗的患者进行了一项回顾性流行病学研究。在总共123名声门下狭窄患者(84名女性,39名男性)中,38名被诊断为ISS,且均为女性。其中,23名居住在挪威东南部地区卫生局辖区,在这个拥有290万居民的地区,发病率为每10万人中有0.2例(95%置信区间0.13 - 0.3)。诊断时的平均年龄为54岁(范围20 - 85岁),症状出现到诊断的平均间隔时间为3.1年。2003年至2013年期间,38名ISS患者共接受了132次手术。所有患者均通过内镜使用激光手术进行治疗,联合或不联合使用皮质类固醇和丝裂霉素C,并通过球囊或探条进行扩张。8名患者(21.1%)仅需一次手术,而30名患者(78.9%)接受了多次手术。所有患者从首次手术起的中位随访时间为5.3年。20 - 48岁患者手术间隔的平均时间为1年,49 - 61岁患者为1.3年,62 - 85岁患者为3.0年。未观察到具有临床意义的并发症。总之,ISS的症状可以通过激光手术和扩张有效治疗,但复发率仍然很高,且手术间隔时间不会随时间增加,这使得ISS仍然是一个持续的挑战。